Grant-Huerta Yanina 4
4 · Atara Biotherapeutics, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Grant-Huerta Yanina
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-11-17$13.19/sh−1,645$21,691→ 33,613 total - Sale
Common Stock
2025-11-17$13.19/sh−74$976→ 33,454 total - Sale
Common Stock
2025-11-17$13.19/sh−85$1,121→ 33,528 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.